SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-19-003863
Filing Date
2019-01-29
Accepted
2019-01-29 08:47:53
Documents
3
Period of Report
2019-01-29

Document Format Files

Seq Description Document Type Size
1 6-K a19-3623_16k.htm 6-K 15539
2 EX-99.1 a19-3623_1ex99d1.htm EX-99.1 23480
3 GRAPHIC g36231mmi001.jpg GRAPHIC 2279
  Complete submission text file 0001104659-19-003863.txt   43331
Mailing Address DARWINWEG 24 LEIDEN P7 2333CR
Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 19547222
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1